Clinical Trials Directory

Trials / Completed

CompletedNCT04284644

Co-induction Technique Compared to Standard Inhalational and Intravenous Induction Techniques

A Novel Co-induction Technique Compared to Standard Inhalational and Intravenous Induction Techniques: a Prospective Randomized Control Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
105 (actual)
Sponsor
University of Jordan · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

Co-induction technique refers to the use of a combination of medications to reach the desired therapeutic target. In the present study, the investigators examined the safety of a novel co-induction approach that relied on a simple timing and dosing alterations to the classical approaches of inhalational sevoflurane and propofol induction. The significance of this study is to find a reliable safe alternative method of induction that can provide optimal parameters,when compared to the classical methods of induction.

Detailed description

Co-induction technique refers to the use of a combination of medications to reach the desired therapeutic target. This technique is considered an approach that can be of a great benefit to patients with chronic medical illnesses and those who have moderate to high risk for general anaesthesia. In the present study, the investigators examined the safety of a novel co-induction approach that relied on a simple timing and dosing alterations to the classical approaches of inhalational sevoflurane and propofol induction. The significance of this study is to find a reliable safe alternative method of induction that can provide optimal parameters,when compared to the classical methods of induction. The investigators evaluated the time needed for laryngeal mask airway (LMA) insertion, number of LMA insertion trials, succession of LMA insertion, adverse events related to the airway, respiratory and cardiovascular systems, haemodynamic stability and satisfaction scores of enrolled patients.

Conditions

Interventions

TypeNameDescription
DRUGInduction using propofolPatients were given 1.5 mcg/Kg of fentanyl intravenously. two minutes after the fentanyl dose, a dose of 1.5 mg/kg of propofol slowly over 2 minutes.
DRUGInduction using sevofluranePatients were given 1.5 mcg/Kg of fentanyl intravenously. two minutes after the fentanyl dose, patient received 8% inhalational sevoflurane through sealed plastic face mask at 8 L/min flow of oxygen.
DRUGInduction using propofol and sevofluranePatients were given 1.5 mcg/Kg of fentanyl intravenously. two minutes after the fentanyl dose, patient received 4% sevoflurane through sealed plastic face mask at 8 L/min flow of oxygen for 2 minutes, followed by a dose of 0.75 mg/kg of propofol given slowly.

Timeline

Start date
2016-05-01
Primary completion
2017-01-02
Completion
2017-01-03
First posted
2020-02-26
Last updated
2020-02-26

Locations

1 site across 1 country: Jordan

Source: ClinicalTrials.gov record NCT04284644. Inclusion in this directory is not an endorsement.